Condition
Newly Diagnosed Glioblastoma Multiforme clinical trials and research
Research outlook What's coming for Glioblastoma: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 Newly Diagnosed Glioblastoma Multiforme clinical trials that are recruiting, at sites in 2 countries (most in United States (1), South Korea (1)). By phase: Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Stem cell–based gene and cell therapy for people with newly diagnosed glioblastoma.
This trial will test whether an injected stem cell therapy carrying a suicide gene is safe for adults with newly diagnosed glioblastoma after surgery.
-
G-CSF after chemo-radiation for MGMT-methylated glioblastoma
This test checks whether giving G-CSF after standard chemo-radiation helps protect brain structure and thinking in adults with newly diagnosed MGMT-methylated glioblastoma.
Related topics
Quick answers
How many Newly Diagnosed Glioblastoma Multiforme clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.